ClinicalTrials.gg
RecruitingNCT01635569Updated May 12, 2023

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

An interventional study of Group-based family cognitive-behavioural therapy and Waitlist in Obsessive-compulsive Disorder, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-05-12.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2012; still recruiting 14 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Non-randomized
Ages
5 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Obsessive-Compulsive Disorder with a site in Canada — 12 open to participants now, 16 under way, none of them phase 3. Obsessive-Compulsive Disorder · Canada.

Planned enrollment
6th of 47
180 · median 39
Started
2012
with 3 others
No phase
33 of 52
7 open now
Primary completion
2027-06
later than 8 of 15 live
Registered
11th of 52
by date
Lead sponsor
6 of 52
University of British Columbia

Among the 52 studies in Obsessive-Compulsive Disorder with a site in Canada, this one is the 6th largest by planned enrollment of the 47 interventional ones that give a count, is one of 4 that started in 2012, is one of 33 with no phase, reaches primary completion later than 8 of the 15 other live ones, and was the 11th registered.

Obsessive-Compulsive Disorder

637 studies on the registry are indexed under Obsessive-Compulsive Disorder; 167 are open to participants now.

Browse Obsessive-Compulsive Disorder studies →

Open to participants now

12 of the 52 studies in Obsessive-Compulsive Disorder with a site in Canada are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 120 Obsessive-Compulsive Disorder studies recruiting now, 30 (25%) set no upper age limit and 82 (68%) stop at 75 or younger; 28 take children under 18; 19 take healthy volunteers.

This study: 5 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Obsessive-Compulsive Disorder with a site in Canada, or all of them as a file.
02

Study summary

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications but access to treatment is difficult and does not systematically include parents. The investigators will evaluate clinical and neural effects of Group-based Family CBT (GF-CBT), via a case-control study including: Group 1 - OCD cases receiving GF-CBT (N=90); Group 2 - OCD waitlist cases (N=90). Effects will be measured between baseline and completion of 12 GF-CBT sessions: comparing OCD severity and functioning changes between Groups 1 and 2.

Read the detailed description

Effective OCD treatment approaches in children and youth include cognitive-behaviour therapy (CBT) and serotonergic medications; however, the disorder is under-diagnosed and access to care is frequently delayed or difficult to obtain. Moreover, despite the important role of family accommodation as an outcome predictor, standard CBT does not systematically include parents and mechanisms of response are not fully understood. The investigators propose to address this challenge by evaluating a novel treatment approach called Group-based Family CBT (GF-CBT).

To determine clinical and neural effects of GF-CBT, we will perform a case-control study of two groups: Group 1 - OCD-affected youth receiving GF-CBT treatment (N=90); Group 2 - OCD-affected youth receiving no new treatment (waitlist controls; N=90).

The investigators will collect clinical outcome data related to OCD severity, individual and family functioning at four time points for Group 1 subjects and at two time points for Group 2 subjects. For Group 1 subjects, these time points include baseline, at midpoint, at the completion of 12 sessions, and at one-month follow-up (all time points are +/- one week). For Group 2 subjects, time points will be at baseline and after a time delay equivalent to completion of 12 GF-CBT sessions. Clinical measures will be used to compare changes between GF-CBT treatment and waitlist-control groups (Groups 1 versus 2).

03

Conditions studied

  • Obsessive-compulsive Disorder

Keywords

  • Obsessive-compulsive disorder
  • Pediatric
  • Group-based
  • Cognitive-behavioural therapy
04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female, aged 5-18 years old
  • Ability of subject and parent to provide informed assent/consent
  • English-speaking
  • Current DSM IV-TR Axis I diagnosis of childhood-onset OCD; Moderate to severe OCD (CY-BOCS≥16/40)

Exclusion criteria

Exclusion Criteria:

  • Current diagnosis of bipolar disorder, psychosis, mental retardation or pervasive developmental disorder (e.g., autism), and current or past substance dependence/abuse
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Active comparator
    OCD-affected subjects (Group 1)

    OCD-affected subjects will participate in 12 sessions of group therapy (as per GF-CBT protocol).

    Behavioral: Group-based family cognitive-behavioural therapy

  • Active comparator
    OCD-affected subjects (Group 2)

    Waitlist affected-controls awaiting a treatment spot.

    Other: Waitlist

Interventions

  • BehavioralGroup-based family cognitive-behavioural therapy

    Baseline and post-12 sessions

  • OtherWaitlist

    Baseline and post-12 sessions

06

What researchers measure

Primary outcomes

  1. Children's Yale Brown Obsessive-Compulsive Scale (CY-BOCS)

    CY-BOCS: gold-standard measure of OCD severity in pediatric OCD.

    Time frame: Baseline, midpoint, completion of 12 GF-CBT sessions, one-month follow-up

07

Study locations

1 of 1 sites recruiting
  • BC Children's Hospital Research Institute
    Vancouver, British Columbia, Canada
    Recruiting
    • S. Evelyn Stewart, MD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2012 (actual). Primary completion is estimated for Jun 2027, 176 months after the start.

Of 235 non-industry interventional studies with no phase under Obsessive-Compulsive Disorder, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 63. This study's planned 176 months is above that.

Counting every sponsor, half of 238 studies reached it within 43 months; a quarter within 22 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2012
First posted
Jul 9, 2012
StartActual
Oct 1, 2012
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
May 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01635569
Collaborators
Michael Smith Foundation for Health Research
Responsible party
Evelyn Stewart, MD (Principle Investigator, University of British Columbia) — Principal investigator
First posted
Jul 9, 2012
Start date
Oct 1, 2012
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
May 12, 2023

Study contacts

Diana Franco Yamin, MA
Contact
dfrancoy@bcchr.ca
S. Evelyn Stewart, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion